Lili Belcastro
Company: Bristol Myers Squibb
Job title: Associate Director
Seminars:
Chair’s Opening Remarks 9:00 am
day: Conference Day Two
Panel Discussion: Shaping the Future of Ancillary Materials in Cell & Gene Therapy Insights from ISO Standard Development 9:10 am
Firsthand experience contributing to a new ISO standard, focused on ancillary materials used in advanced therapies Overview of the U.S. TAG validation process and transition to a New Work Item Proposal within the ISO framework What this upcoming standard means for developers, manufacturers, and regulators over the next 3 to 4 yearsRead more
day: Conference Day Two
Chair’s Closing Remarks 5:15 pm
day: Conference Day Two